Co-prevalence of Substance Use Disorders and Common AxisⅠDisorders in Yunnan's Drug Users
Background Mental disorders in drug users have received increasing attention. However, there are no any epidemiologic data available in regard to substance use disorders (SUD) and other mental disorders in drug users in Yunnan, one region that is hit hardest by epidemic of drug use in China. Objecti...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
ZHANG Guanbai, ZHENG Ling, YANG Liping, ZHOU Qin, WANG Fei, HE Liangze, CHENG Xuan, CHA Li, LI Xinyue [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Chinesisch |
| Erschienen: |
2022 |
|---|
| Schlagwörter: |
|---|
| Übergeordnetes Werk: |
In: Zhongguo quanke yixue - Chinese General Practice Publishing House Co., Ltd, 2024, 25(2022), 36, Seite 4554-4560 |
|---|---|
| Übergeordnetes Werk: |
volume:25 ; year:2022 ; number:36 ; pages:4554-4560 |
| Links: |
|---|
| DOI / URN: |
10.12114/j.issn.1007-9572.2022.0426 |
|---|
| Katalog-ID: |
DOAJ091500354 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ091500354 | ||
| 003 | DE-627 | ||
| 005 | 20240412094020.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240412s2022 xx |||||o 00| ||chi c | ||
| 024 | 7 | |a 10.12114/j.issn.1007-9572.2022.0426 |2 doi | |
| 035 | |a (DE-627)DOAJ091500354 | ||
| 035 | |a (DE-599)DOAJa51c860eed184d38b267f2ff189b1b8f | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a chi | ||
| 100 | 0 | |a ZHANG Guanbai, ZHENG Ling, YANG Liping, ZHOU Qin, WANG Fei, HE Liangze, CHENG Xuan, CHA Li, LI Xinyue |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Co-prevalence of Substance Use Disorders and Common AxisⅠDisorders in Yunnan's Drug Users |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Background Mental disorders in drug users have received increasing attention. However, there are no any epidemiologic data available in regard to substance use disorders (SUD) and other mental disorders in drug users in Yunnan, one region that is hit hardest by epidemic of drug use in China. Objective To investigate the co-prevalence of SUD and a common mental disorder, axisⅠdisorders, among Yunnan's drug users. Methods A cross-sectional survey was conducted among a convenient sample of 598 male drug users who received detoxification treatment from the 5th Compulsory Detention and Forced Detoxification Center of Yunnan Province and Dali Compulsory Detention and Forced Detoxification Center between August and November, 2020. According to the diagnosis of SUD, the participants were divided into three groups: opioid use disorder group (n=245) , methamphetamine use disorder group (n=197) and double use disorder group (n=146) . The Chinese version of SCID-Ⅰ/P was used to assess the prevalence of common axisⅠmental disorders (psychosis disorder, affective disorder, alcohol use disorder, and sedative-hypnotic use disorder) . The lifetime prevalence of these disorders among the three groups was compared. Results Among the 598 cases, there were 588 cases diagnosed with SUD (opioid, methamphetamine, or both) . The lifetime prevalence of psychosis disorder, alcohol use disorder, sedative and hypnotic use disorder among the three groups was significantly different (P < 0.05) . The overall lifetime prevalence of schizophrenia, other primary and drug induced psychotic disorders was 15.82%. The lifetime prevalence of psychotic disorder in opioid use disorder group (5.31%) was lower than that of methamphetamine use disorder group (20.30%) or that of double use disorder group (27.40%) (P<0.05) . The overall lifetime prevalence of affective disorders was 21.77%. To be specific, the lifetime prevalence of affective disorders was 17.14% in opioid use disorder group, 25.38% in methamphetamine use disorder group, and 24.66% in double use disorder group. The overall lifetime prevalence of alcohol use disorder was 42.18%. Specifically, opioid use disorder group had lower lifetime prevalence of alcohol use disorder than methamphetamine use disorder group (35.10% vs 45.69%) and than double use disorder group (35.10% vs 49.32%) (P<0.05) . The overall lifetime prevalence of sedative or hypnotic use disorder was 13.61%. The lifetime prevalence of sedative or hypnotic use disorder was 19.18%, 22.60% and 0 in opioid use disorder group, double use disorder group, and methamphetamine use disorder group, respectively. Conclusion The prevalence of the above-mentioned mental disorders in drug users in Yunnan Province was much higher than that in the general population. Moreover, these mental disorders may be even more prevalent in methamphetamine use disorder population than in opioid use disorder population. | ||
| 650 | 4 | |a substance-related disorders|opioid-related disorders|methamphetamine|schizophrenia|psychotic disorders|drug users|yunnan|cross-sectional studies | |
| 653 | 0 | |a Medicine | |
| 653 | 0 | |a R | |
| 773 | 0 | 8 | |i In |t Zhongguo quanke yixue |d Chinese General Practice Publishing House Co., Ltd, 2024 |g 25(2022), 36, Seite 4554-4560 |w (DE-627)DOAJ090664779 |x 10079572 |7 nnns |
| 773 | 1 | 8 | |g volume:25 |g year:2022 |g number:36 |g pages:4554-4560 |
| 856 | 4 | 0 | |u https://doi.org/10.12114/j.issn.1007-9572.2022.0426 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/a51c860eed184d38b267f2ff189b1b8f |z kostenfrei |
| 856 | 4 | 0 | |u https://www.chinagp.net/fileup/1007-9572/PDF/zx20220426.pdf |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/1007-9572 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 951 | |a AR | ||
| 952 | |d 25 |j 2022 |e 36 |h 4554-4560 | ||
| author_variant |
g z l y l z q w f h l c x c l l x z gzlylzqwfhlcxcllx gzlylzqwfhlcxcllxz |
|---|---|
| matchkey_str |
article:10079572:2022----::orvlnefusacueiodradomnxsiod |
| hierarchy_sort_str |
2022 |
| publishDate |
2022 |
| allfields |
10.12114/j.issn.1007-9572.2022.0426 doi (DE-627)DOAJ091500354 (DE-599)DOAJa51c860eed184d38b267f2ff189b1b8f DE-627 ger DE-627 rakwb chi ZHANG Guanbai, ZHENG Ling, YANG Liping, ZHOU Qin, WANG Fei, HE Liangze, CHENG Xuan, CHA Li, LI Xinyue verfasserin aut Co-prevalence of Substance Use Disorders and Common AxisⅠDisorders in Yunnan's Drug Users 2022 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Background Mental disorders in drug users have received increasing attention. However, there are no any epidemiologic data available in regard to substance use disorders (SUD) and other mental disorders in drug users in Yunnan, one region that is hit hardest by epidemic of drug use in China. Objective To investigate the co-prevalence of SUD and a common mental disorder, axisⅠdisorders, among Yunnan's drug users. Methods A cross-sectional survey was conducted among a convenient sample of 598 male drug users who received detoxification treatment from the 5th Compulsory Detention and Forced Detoxification Center of Yunnan Province and Dali Compulsory Detention and Forced Detoxification Center between August and November, 2020. According to the diagnosis of SUD, the participants were divided into three groups: opioid use disorder group (n=245) , methamphetamine use disorder group (n=197) and double use disorder group (n=146) . The Chinese version of SCID-Ⅰ/P was used to assess the prevalence of common axisⅠmental disorders (psychosis disorder, affective disorder, alcohol use disorder, and sedative-hypnotic use disorder) . The lifetime prevalence of these disorders among the three groups was compared. Results Among the 598 cases, there were 588 cases diagnosed with SUD (opioid, methamphetamine, or both) . The lifetime prevalence of psychosis disorder, alcohol use disorder, sedative and hypnotic use disorder among the three groups was significantly different (P < 0.05) . The overall lifetime prevalence of schizophrenia, other primary and drug induced psychotic disorders was 15.82%. The lifetime prevalence of psychotic disorder in opioid use disorder group (5.31%) was lower than that of methamphetamine use disorder group (20.30%) or that of double use disorder group (27.40%) (P<0.05) . The overall lifetime prevalence of affective disorders was 21.77%. To be specific, the lifetime prevalence of affective disorders was 17.14% in opioid use disorder group, 25.38% in methamphetamine use disorder group, and 24.66% in double use disorder group. The overall lifetime prevalence of alcohol use disorder was 42.18%. Specifically, opioid use disorder group had lower lifetime prevalence of alcohol use disorder than methamphetamine use disorder group (35.10% vs 45.69%) and than double use disorder group (35.10% vs 49.32%) (P<0.05) . The overall lifetime prevalence of sedative or hypnotic use disorder was 13.61%. The lifetime prevalence of sedative or hypnotic use disorder was 19.18%, 22.60% and 0 in opioid use disorder group, double use disorder group, and methamphetamine use disorder group, respectively. Conclusion The prevalence of the above-mentioned mental disorders in drug users in Yunnan Province was much higher than that in the general population. Moreover, these mental disorders may be even more prevalent in methamphetamine use disorder population than in opioid use disorder population. substance-related disorders|opioid-related disorders|methamphetamine|schizophrenia|psychotic disorders|drug users|yunnan|cross-sectional studies Medicine R In Zhongguo quanke yixue Chinese General Practice Publishing House Co., Ltd, 2024 25(2022), 36, Seite 4554-4560 (DE-627)DOAJ090664779 10079572 nnns volume:25 year:2022 number:36 pages:4554-4560 https://doi.org/10.12114/j.issn.1007-9572.2022.0426 kostenfrei https://doaj.org/article/a51c860eed184d38b267f2ff189b1b8f kostenfrei https://www.chinagp.net/fileup/1007-9572/PDF/zx20220426.pdf kostenfrei https://doaj.org/toc/1007-9572 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 25 2022 36 4554-4560 |
| spelling |
10.12114/j.issn.1007-9572.2022.0426 doi (DE-627)DOAJ091500354 (DE-599)DOAJa51c860eed184d38b267f2ff189b1b8f DE-627 ger DE-627 rakwb chi ZHANG Guanbai, ZHENG Ling, YANG Liping, ZHOU Qin, WANG Fei, HE Liangze, CHENG Xuan, CHA Li, LI Xinyue verfasserin aut Co-prevalence of Substance Use Disorders and Common AxisⅠDisorders in Yunnan's Drug Users 2022 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Background Mental disorders in drug users have received increasing attention. However, there are no any epidemiologic data available in regard to substance use disorders (SUD) and other mental disorders in drug users in Yunnan, one region that is hit hardest by epidemic of drug use in China. Objective To investigate the co-prevalence of SUD and a common mental disorder, axisⅠdisorders, among Yunnan's drug users. Methods A cross-sectional survey was conducted among a convenient sample of 598 male drug users who received detoxification treatment from the 5th Compulsory Detention and Forced Detoxification Center of Yunnan Province and Dali Compulsory Detention and Forced Detoxification Center between August and November, 2020. According to the diagnosis of SUD, the participants were divided into three groups: opioid use disorder group (n=245) , methamphetamine use disorder group (n=197) and double use disorder group (n=146) . The Chinese version of SCID-Ⅰ/P was used to assess the prevalence of common axisⅠmental disorders (psychosis disorder, affective disorder, alcohol use disorder, and sedative-hypnotic use disorder) . The lifetime prevalence of these disorders among the three groups was compared. Results Among the 598 cases, there were 588 cases diagnosed with SUD (opioid, methamphetamine, or both) . The lifetime prevalence of psychosis disorder, alcohol use disorder, sedative and hypnotic use disorder among the three groups was significantly different (P < 0.05) . The overall lifetime prevalence of schizophrenia, other primary and drug induced psychotic disorders was 15.82%. The lifetime prevalence of psychotic disorder in opioid use disorder group (5.31%) was lower than that of methamphetamine use disorder group (20.30%) or that of double use disorder group (27.40%) (P<0.05) . The overall lifetime prevalence of affective disorders was 21.77%. To be specific, the lifetime prevalence of affective disorders was 17.14% in opioid use disorder group, 25.38% in methamphetamine use disorder group, and 24.66% in double use disorder group. The overall lifetime prevalence of alcohol use disorder was 42.18%. Specifically, opioid use disorder group had lower lifetime prevalence of alcohol use disorder than methamphetamine use disorder group (35.10% vs 45.69%) and than double use disorder group (35.10% vs 49.32%) (P<0.05) . The overall lifetime prevalence of sedative or hypnotic use disorder was 13.61%. The lifetime prevalence of sedative or hypnotic use disorder was 19.18%, 22.60% and 0 in opioid use disorder group, double use disorder group, and methamphetamine use disorder group, respectively. Conclusion The prevalence of the above-mentioned mental disorders in drug users in Yunnan Province was much higher than that in the general population. Moreover, these mental disorders may be even more prevalent in methamphetamine use disorder population than in opioid use disorder population. substance-related disorders|opioid-related disorders|methamphetamine|schizophrenia|psychotic disorders|drug users|yunnan|cross-sectional studies Medicine R In Zhongguo quanke yixue Chinese General Practice Publishing House Co., Ltd, 2024 25(2022), 36, Seite 4554-4560 (DE-627)DOAJ090664779 10079572 nnns volume:25 year:2022 number:36 pages:4554-4560 https://doi.org/10.12114/j.issn.1007-9572.2022.0426 kostenfrei https://doaj.org/article/a51c860eed184d38b267f2ff189b1b8f kostenfrei https://www.chinagp.net/fileup/1007-9572/PDF/zx20220426.pdf kostenfrei https://doaj.org/toc/1007-9572 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 25 2022 36 4554-4560 |
| allfields_unstemmed |
10.12114/j.issn.1007-9572.2022.0426 doi (DE-627)DOAJ091500354 (DE-599)DOAJa51c860eed184d38b267f2ff189b1b8f DE-627 ger DE-627 rakwb chi ZHANG Guanbai, ZHENG Ling, YANG Liping, ZHOU Qin, WANG Fei, HE Liangze, CHENG Xuan, CHA Li, LI Xinyue verfasserin aut Co-prevalence of Substance Use Disorders and Common AxisⅠDisorders in Yunnan's Drug Users 2022 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Background Mental disorders in drug users have received increasing attention. However, there are no any epidemiologic data available in regard to substance use disorders (SUD) and other mental disorders in drug users in Yunnan, one region that is hit hardest by epidemic of drug use in China. Objective To investigate the co-prevalence of SUD and a common mental disorder, axisⅠdisorders, among Yunnan's drug users. Methods A cross-sectional survey was conducted among a convenient sample of 598 male drug users who received detoxification treatment from the 5th Compulsory Detention and Forced Detoxification Center of Yunnan Province and Dali Compulsory Detention and Forced Detoxification Center between August and November, 2020. According to the diagnosis of SUD, the participants were divided into three groups: opioid use disorder group (n=245) , methamphetamine use disorder group (n=197) and double use disorder group (n=146) . The Chinese version of SCID-Ⅰ/P was used to assess the prevalence of common axisⅠmental disorders (psychosis disorder, affective disorder, alcohol use disorder, and sedative-hypnotic use disorder) . The lifetime prevalence of these disorders among the three groups was compared. Results Among the 598 cases, there were 588 cases diagnosed with SUD (opioid, methamphetamine, or both) . The lifetime prevalence of psychosis disorder, alcohol use disorder, sedative and hypnotic use disorder among the three groups was significantly different (P < 0.05) . The overall lifetime prevalence of schizophrenia, other primary and drug induced psychotic disorders was 15.82%. The lifetime prevalence of psychotic disorder in opioid use disorder group (5.31%) was lower than that of methamphetamine use disorder group (20.30%) or that of double use disorder group (27.40%) (P<0.05) . The overall lifetime prevalence of affective disorders was 21.77%. To be specific, the lifetime prevalence of affective disorders was 17.14% in opioid use disorder group, 25.38% in methamphetamine use disorder group, and 24.66% in double use disorder group. The overall lifetime prevalence of alcohol use disorder was 42.18%. Specifically, opioid use disorder group had lower lifetime prevalence of alcohol use disorder than methamphetamine use disorder group (35.10% vs 45.69%) and than double use disorder group (35.10% vs 49.32%) (P<0.05) . The overall lifetime prevalence of sedative or hypnotic use disorder was 13.61%. The lifetime prevalence of sedative or hypnotic use disorder was 19.18%, 22.60% and 0 in opioid use disorder group, double use disorder group, and methamphetamine use disorder group, respectively. Conclusion The prevalence of the above-mentioned mental disorders in drug users in Yunnan Province was much higher than that in the general population. Moreover, these mental disorders may be even more prevalent in methamphetamine use disorder population than in opioid use disorder population. substance-related disorders|opioid-related disorders|methamphetamine|schizophrenia|psychotic disorders|drug users|yunnan|cross-sectional studies Medicine R In Zhongguo quanke yixue Chinese General Practice Publishing House Co., Ltd, 2024 25(2022), 36, Seite 4554-4560 (DE-627)DOAJ090664779 10079572 nnns volume:25 year:2022 number:36 pages:4554-4560 https://doi.org/10.12114/j.issn.1007-9572.2022.0426 kostenfrei https://doaj.org/article/a51c860eed184d38b267f2ff189b1b8f kostenfrei https://www.chinagp.net/fileup/1007-9572/PDF/zx20220426.pdf kostenfrei https://doaj.org/toc/1007-9572 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 25 2022 36 4554-4560 |
| allfieldsGer |
10.12114/j.issn.1007-9572.2022.0426 doi (DE-627)DOAJ091500354 (DE-599)DOAJa51c860eed184d38b267f2ff189b1b8f DE-627 ger DE-627 rakwb chi ZHANG Guanbai, ZHENG Ling, YANG Liping, ZHOU Qin, WANG Fei, HE Liangze, CHENG Xuan, CHA Li, LI Xinyue verfasserin aut Co-prevalence of Substance Use Disorders and Common AxisⅠDisorders in Yunnan's Drug Users 2022 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Background Mental disorders in drug users have received increasing attention. However, there are no any epidemiologic data available in regard to substance use disorders (SUD) and other mental disorders in drug users in Yunnan, one region that is hit hardest by epidemic of drug use in China. Objective To investigate the co-prevalence of SUD and a common mental disorder, axisⅠdisorders, among Yunnan's drug users. Methods A cross-sectional survey was conducted among a convenient sample of 598 male drug users who received detoxification treatment from the 5th Compulsory Detention and Forced Detoxification Center of Yunnan Province and Dali Compulsory Detention and Forced Detoxification Center between August and November, 2020. According to the diagnosis of SUD, the participants were divided into three groups: opioid use disorder group (n=245) , methamphetamine use disorder group (n=197) and double use disorder group (n=146) . The Chinese version of SCID-Ⅰ/P was used to assess the prevalence of common axisⅠmental disorders (psychosis disorder, affective disorder, alcohol use disorder, and sedative-hypnotic use disorder) . The lifetime prevalence of these disorders among the three groups was compared. Results Among the 598 cases, there were 588 cases diagnosed with SUD (opioid, methamphetamine, or both) . The lifetime prevalence of psychosis disorder, alcohol use disorder, sedative and hypnotic use disorder among the three groups was significantly different (P < 0.05) . The overall lifetime prevalence of schizophrenia, other primary and drug induced psychotic disorders was 15.82%. The lifetime prevalence of psychotic disorder in opioid use disorder group (5.31%) was lower than that of methamphetamine use disorder group (20.30%) or that of double use disorder group (27.40%) (P<0.05) . The overall lifetime prevalence of affective disorders was 21.77%. To be specific, the lifetime prevalence of affective disorders was 17.14% in opioid use disorder group, 25.38% in methamphetamine use disorder group, and 24.66% in double use disorder group. The overall lifetime prevalence of alcohol use disorder was 42.18%. Specifically, opioid use disorder group had lower lifetime prevalence of alcohol use disorder than methamphetamine use disorder group (35.10% vs 45.69%) and than double use disorder group (35.10% vs 49.32%) (P<0.05) . The overall lifetime prevalence of sedative or hypnotic use disorder was 13.61%. The lifetime prevalence of sedative or hypnotic use disorder was 19.18%, 22.60% and 0 in opioid use disorder group, double use disorder group, and methamphetamine use disorder group, respectively. Conclusion The prevalence of the above-mentioned mental disorders in drug users in Yunnan Province was much higher than that in the general population. Moreover, these mental disorders may be even more prevalent in methamphetamine use disorder population than in opioid use disorder population. substance-related disorders|opioid-related disorders|methamphetamine|schizophrenia|psychotic disorders|drug users|yunnan|cross-sectional studies Medicine R In Zhongguo quanke yixue Chinese General Practice Publishing House Co., Ltd, 2024 25(2022), 36, Seite 4554-4560 (DE-627)DOAJ090664779 10079572 nnns volume:25 year:2022 number:36 pages:4554-4560 https://doi.org/10.12114/j.issn.1007-9572.2022.0426 kostenfrei https://doaj.org/article/a51c860eed184d38b267f2ff189b1b8f kostenfrei https://www.chinagp.net/fileup/1007-9572/PDF/zx20220426.pdf kostenfrei https://doaj.org/toc/1007-9572 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 25 2022 36 4554-4560 |
| allfieldsSound |
10.12114/j.issn.1007-9572.2022.0426 doi (DE-627)DOAJ091500354 (DE-599)DOAJa51c860eed184d38b267f2ff189b1b8f DE-627 ger DE-627 rakwb chi ZHANG Guanbai, ZHENG Ling, YANG Liping, ZHOU Qin, WANG Fei, HE Liangze, CHENG Xuan, CHA Li, LI Xinyue verfasserin aut Co-prevalence of Substance Use Disorders and Common AxisⅠDisorders in Yunnan's Drug Users 2022 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Background Mental disorders in drug users have received increasing attention. However, there are no any epidemiologic data available in regard to substance use disorders (SUD) and other mental disorders in drug users in Yunnan, one region that is hit hardest by epidemic of drug use in China. Objective To investigate the co-prevalence of SUD and a common mental disorder, axisⅠdisorders, among Yunnan's drug users. Methods A cross-sectional survey was conducted among a convenient sample of 598 male drug users who received detoxification treatment from the 5th Compulsory Detention and Forced Detoxification Center of Yunnan Province and Dali Compulsory Detention and Forced Detoxification Center between August and November, 2020. According to the diagnosis of SUD, the participants were divided into three groups: opioid use disorder group (n=245) , methamphetamine use disorder group (n=197) and double use disorder group (n=146) . The Chinese version of SCID-Ⅰ/P was used to assess the prevalence of common axisⅠmental disorders (psychosis disorder, affective disorder, alcohol use disorder, and sedative-hypnotic use disorder) . The lifetime prevalence of these disorders among the three groups was compared. Results Among the 598 cases, there were 588 cases diagnosed with SUD (opioid, methamphetamine, or both) . The lifetime prevalence of psychosis disorder, alcohol use disorder, sedative and hypnotic use disorder among the three groups was significantly different (P < 0.05) . The overall lifetime prevalence of schizophrenia, other primary and drug induced psychotic disorders was 15.82%. The lifetime prevalence of psychotic disorder in opioid use disorder group (5.31%) was lower than that of methamphetamine use disorder group (20.30%) or that of double use disorder group (27.40%) (P<0.05) . The overall lifetime prevalence of affective disorders was 21.77%. To be specific, the lifetime prevalence of affective disorders was 17.14% in opioid use disorder group, 25.38% in methamphetamine use disorder group, and 24.66% in double use disorder group. The overall lifetime prevalence of alcohol use disorder was 42.18%. Specifically, opioid use disorder group had lower lifetime prevalence of alcohol use disorder than methamphetamine use disorder group (35.10% vs 45.69%) and than double use disorder group (35.10% vs 49.32%) (P<0.05) . The overall lifetime prevalence of sedative or hypnotic use disorder was 13.61%. The lifetime prevalence of sedative or hypnotic use disorder was 19.18%, 22.60% and 0 in opioid use disorder group, double use disorder group, and methamphetamine use disorder group, respectively. Conclusion The prevalence of the above-mentioned mental disorders in drug users in Yunnan Province was much higher than that in the general population. Moreover, these mental disorders may be even more prevalent in methamphetamine use disorder population than in opioid use disorder population. substance-related disorders|opioid-related disorders|methamphetamine|schizophrenia|psychotic disorders|drug users|yunnan|cross-sectional studies Medicine R In Zhongguo quanke yixue Chinese General Practice Publishing House Co., Ltd, 2024 25(2022), 36, Seite 4554-4560 (DE-627)DOAJ090664779 10079572 nnns volume:25 year:2022 number:36 pages:4554-4560 https://doi.org/10.12114/j.issn.1007-9572.2022.0426 kostenfrei https://doaj.org/article/a51c860eed184d38b267f2ff189b1b8f kostenfrei https://www.chinagp.net/fileup/1007-9572/PDF/zx20220426.pdf kostenfrei https://doaj.org/toc/1007-9572 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 25 2022 36 4554-4560 |
| language |
Chinese |
| source |
In Zhongguo quanke yixue 25(2022), 36, Seite 4554-4560 volume:25 year:2022 number:36 pages:4554-4560 |
| sourceStr |
In Zhongguo quanke yixue 25(2022), 36, Seite 4554-4560 volume:25 year:2022 number:36 pages:4554-4560 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| topic_facet |
substance-related disorders|opioid-related disorders|methamphetamine|schizophrenia|psychotic disorders|drug users|yunnan|cross-sectional studies Medicine R |
| isfreeaccess_bool |
true |
| container_title |
Zhongguo quanke yixue |
| authorswithroles_txt_mv |
ZHANG Guanbai, ZHENG Ling, YANG Liping, ZHOU Qin, WANG Fei, HE Liangze, CHENG Xuan, CHA Li, LI Xinyue @@aut@@ |
| publishDateDaySort_date |
2022-01-01T00:00:00Z |
| hierarchy_top_id |
DOAJ090664779 |
| id |
DOAJ091500354 |
| language_de |
chinesisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000naa a22002652 4500</leader><controlfield tag="001">DOAJ091500354</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20240412094020.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">240412s2022 xx |||||o 00| ||chi c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.12114/j.issn.1007-9572.2022.0426</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ091500354</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJa51c860eed184d38b267f2ff189b1b8f</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">chi</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">ZHANG Guanbai, ZHENG Ling, YANG Liping, ZHOU Qin, WANG Fei, HE Liangze, CHENG Xuan, CHA Li, LI Xinyue</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Co-prevalence of Substance Use Disorders and Common AxisⅠDisorders in Yunnan's Drug Users</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2022</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Background Mental disorders in drug users have received increasing attention. However, there are no any epidemiologic data available in regard to substance use disorders (SUD) and other mental disorders in drug users in Yunnan, one region that is hit hardest by epidemic of drug use in China. Objective To investigate the co-prevalence of SUD and a common mental disorder, axisⅠdisorders, among Yunnan's drug users. Methods A cross-sectional survey was conducted among a convenient sample of 598 male drug users who received detoxification treatment from the 5th Compulsory Detention and Forced Detoxification Center of Yunnan Province and Dali Compulsory Detention and Forced Detoxification Center between August and November, 2020. According to the diagnosis of SUD, the participants were divided into three groups: opioid use disorder group (n=245) , methamphetamine use disorder group (n=197) and double use disorder group (n=146) . The Chinese version of SCID-Ⅰ/P was used to assess the prevalence of common axisⅠmental disorders (psychosis disorder, affective disorder, alcohol use disorder, and sedative-hypnotic use disorder) . The lifetime prevalence of these disorders among the three groups was compared. Results Among the 598 cases, there were 588 cases diagnosed with SUD (opioid, methamphetamine, or both) . The lifetime prevalence of psychosis disorder, alcohol use disorder, sedative and hypnotic use disorder among the three groups was significantly different (P &lt; 0.05) . The overall lifetime prevalence of schizophrenia, other primary and drug induced psychotic disorders was 15.82%. The lifetime prevalence of psychotic disorder in opioid use disorder group (5.31%) was lower than that of methamphetamine use disorder group (20.30%) or that of double use disorder group (27.40%) (P&lt;0.05) . The overall lifetime prevalence of affective disorders was 21.77%. To be specific, the lifetime prevalence of affective disorders was 17.14% in opioid use disorder group, 25.38% in methamphetamine use disorder group, and 24.66% in double use disorder group. The overall lifetime prevalence of alcohol use disorder was 42.18%. Specifically, opioid use disorder group had lower lifetime prevalence of alcohol use disorder than methamphetamine use disorder group (35.10% vs 45.69%) and than double use disorder group (35.10% vs 49.32%) (P&lt;0.05) . The overall lifetime prevalence of sedative or hypnotic use disorder was 13.61%. The lifetime prevalence of sedative or hypnotic use disorder was 19.18%, 22.60% and 0 in opioid use disorder group, double use disorder group, and methamphetamine use disorder group, respectively. Conclusion The prevalence of the above-mentioned mental disorders in drug users in Yunnan Province was much higher than that in the general population. Moreover, these mental disorders may be even more prevalent in methamphetamine use disorder population than in opioid use disorder population.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">substance-related disorders|opioid-related disorders|methamphetamine|schizophrenia|psychotic disorders|drug users|yunnan|cross-sectional studies</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Medicine</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">R</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Zhongguo quanke yixue</subfield><subfield code="d">Chinese General Practice Publishing House Co., Ltd, 2024</subfield><subfield code="g">25(2022), 36, Seite 4554-4560</subfield><subfield code="w">(DE-627)DOAJ090664779</subfield><subfield code="x">10079572</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:25</subfield><subfield code="g">year:2022</subfield><subfield code="g">number:36</subfield><subfield code="g">pages:4554-4560</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.12114/j.issn.1007-9572.2022.0426</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/a51c860eed184d38b267f2ff189b1b8f</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://www.chinagp.net/fileup/1007-9572/PDF/zx20220426.pdf</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1007-9572</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">25</subfield><subfield code="j">2022</subfield><subfield code="e">36</subfield><subfield code="h">4554-4560</subfield></datafield></record></collection>
|
| author |
ZHANG Guanbai, ZHENG Ling, YANG Liping, ZHOU Qin, WANG Fei, HE Liangze, CHENG Xuan, CHA Li, LI Xinyue |
| spellingShingle |
ZHANG Guanbai, ZHENG Ling, YANG Liping, ZHOU Qin, WANG Fei, HE Liangze, CHENG Xuan, CHA Li, LI Xinyue misc substance-related disorders|opioid-related disorders|methamphetamine|schizophrenia|psychotic disorders|drug users|yunnan|cross-sectional studies misc Medicine misc R Co-prevalence of Substance Use Disorders and Common AxisⅠDisorders in Yunnan's Drug Users |
| authorStr |
ZHANG Guanbai, ZHENG Ling, YANG Liping, ZHOU Qin, WANG Fei, HE Liangze, CHENG Xuan, CHA Li, LI Xinyue |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)DOAJ090664779 |
| format |
electronic Article |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
DOAJ |
| remote_str |
true |
| illustrated |
Not Illustrated |
| issn |
10079572 |
| topic_title |
Co-prevalence of Substance Use Disorders and Common AxisⅠDisorders in Yunnan's Drug Users substance-related disorders|opioid-related disorders|methamphetamine|schizophrenia|psychotic disorders|drug users|yunnan|cross-sectional studies |
| topic |
misc substance-related disorders|opioid-related disorders|methamphetamine|schizophrenia|psychotic disorders|drug users|yunnan|cross-sectional studies misc Medicine misc R |
| topic_unstemmed |
misc substance-related disorders|opioid-related disorders|methamphetamine|schizophrenia|psychotic disorders|drug users|yunnan|cross-sectional studies misc Medicine misc R |
| topic_browse |
misc substance-related disorders|opioid-related disorders|methamphetamine|schizophrenia|psychotic disorders|drug users|yunnan|cross-sectional studies misc Medicine misc R |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
cr |
| hierarchy_parent_title |
Zhongguo quanke yixue |
| hierarchy_parent_id |
DOAJ090664779 |
| hierarchy_top_title |
Zhongguo quanke yixue |
| isfreeaccess_txt |
true |
| familylinks_str_mv |
(DE-627)DOAJ090664779 |
| title |
Co-prevalence of Substance Use Disorders and Common AxisⅠDisorders in Yunnan's Drug Users |
| ctrlnum |
(DE-627)DOAJ091500354 (DE-599)DOAJa51c860eed184d38b267f2ff189b1b8f |
| title_full |
Co-prevalence of Substance Use Disorders and Common AxisⅠDisorders in Yunnan's Drug Users |
| author_sort |
ZHANG Guanbai, ZHENG Ling, YANG Liping, ZHOU Qin, WANG Fei, HE Liangze, CHENG Xuan, CHA Li, LI Xinyue |
| journal |
Zhongguo quanke yixue |
| journalStr |
Zhongguo quanke yixue |
| lang_code |
chi |
| isOA_bool |
true |
| recordtype |
marc |
| publishDateSort |
2022 |
| contenttype_str_mv |
txt |
| container_start_page |
4554 |
| author_browse |
ZHANG Guanbai, ZHENG Ling, YANG Liping, ZHOU Qin, WANG Fei, HE Liangze, CHENG Xuan, CHA Li, LI Xinyue |
| container_volume |
25 |
| format_se |
Elektronische Aufsätze |
| author-letter |
ZHANG Guanbai, ZHENG Ling, YANG Liping, ZHOU Qin, WANG Fei, HE Liangze, CHENG Xuan, CHA Li, LI Xinyue |
| doi_str_mv |
10.12114/j.issn.1007-9572.2022.0426 |
| title_sort |
co-prevalence of substance use disorders and common axisⅰdisorders in yunnan's drug users |
| title_auth |
Co-prevalence of Substance Use Disorders and Common AxisⅠDisorders in Yunnan's Drug Users |
| abstract |
Background Mental disorders in drug users have received increasing attention. However, there are no any epidemiologic data available in regard to substance use disorders (SUD) and other mental disorders in drug users in Yunnan, one region that is hit hardest by epidemic of drug use in China. Objective To investigate the co-prevalence of SUD and a common mental disorder, axisⅠdisorders, among Yunnan's drug users. Methods A cross-sectional survey was conducted among a convenient sample of 598 male drug users who received detoxification treatment from the 5th Compulsory Detention and Forced Detoxification Center of Yunnan Province and Dali Compulsory Detention and Forced Detoxification Center between August and November, 2020. According to the diagnosis of SUD, the participants were divided into three groups: opioid use disorder group (n=245) , methamphetamine use disorder group (n=197) and double use disorder group (n=146) . The Chinese version of SCID-Ⅰ/P was used to assess the prevalence of common axisⅠmental disorders (psychosis disorder, affective disorder, alcohol use disorder, and sedative-hypnotic use disorder) . The lifetime prevalence of these disorders among the three groups was compared. Results Among the 598 cases, there were 588 cases diagnosed with SUD (opioid, methamphetamine, or both) . The lifetime prevalence of psychosis disorder, alcohol use disorder, sedative and hypnotic use disorder among the three groups was significantly different (P < 0.05) . The overall lifetime prevalence of schizophrenia, other primary and drug induced psychotic disorders was 15.82%. The lifetime prevalence of psychotic disorder in opioid use disorder group (5.31%) was lower than that of methamphetamine use disorder group (20.30%) or that of double use disorder group (27.40%) (P<0.05) . The overall lifetime prevalence of affective disorders was 21.77%. To be specific, the lifetime prevalence of affective disorders was 17.14% in opioid use disorder group, 25.38% in methamphetamine use disorder group, and 24.66% in double use disorder group. The overall lifetime prevalence of alcohol use disorder was 42.18%. Specifically, opioid use disorder group had lower lifetime prevalence of alcohol use disorder than methamphetamine use disorder group (35.10% vs 45.69%) and than double use disorder group (35.10% vs 49.32%) (P<0.05) . The overall lifetime prevalence of sedative or hypnotic use disorder was 13.61%. The lifetime prevalence of sedative or hypnotic use disorder was 19.18%, 22.60% and 0 in opioid use disorder group, double use disorder group, and methamphetamine use disorder group, respectively. Conclusion The prevalence of the above-mentioned mental disorders in drug users in Yunnan Province was much higher than that in the general population. Moreover, these mental disorders may be even more prevalent in methamphetamine use disorder population than in opioid use disorder population. |
| abstractGer |
Background Mental disorders in drug users have received increasing attention. However, there are no any epidemiologic data available in regard to substance use disorders (SUD) and other mental disorders in drug users in Yunnan, one region that is hit hardest by epidemic of drug use in China. Objective To investigate the co-prevalence of SUD and a common mental disorder, axisⅠdisorders, among Yunnan's drug users. Methods A cross-sectional survey was conducted among a convenient sample of 598 male drug users who received detoxification treatment from the 5th Compulsory Detention and Forced Detoxification Center of Yunnan Province and Dali Compulsory Detention and Forced Detoxification Center between August and November, 2020. According to the diagnosis of SUD, the participants were divided into three groups: opioid use disorder group (n=245) , methamphetamine use disorder group (n=197) and double use disorder group (n=146) . The Chinese version of SCID-Ⅰ/P was used to assess the prevalence of common axisⅠmental disorders (psychosis disorder, affective disorder, alcohol use disorder, and sedative-hypnotic use disorder) . The lifetime prevalence of these disorders among the three groups was compared. Results Among the 598 cases, there were 588 cases diagnosed with SUD (opioid, methamphetamine, or both) . The lifetime prevalence of psychosis disorder, alcohol use disorder, sedative and hypnotic use disorder among the three groups was significantly different (P < 0.05) . The overall lifetime prevalence of schizophrenia, other primary and drug induced psychotic disorders was 15.82%. The lifetime prevalence of psychotic disorder in opioid use disorder group (5.31%) was lower than that of methamphetamine use disorder group (20.30%) or that of double use disorder group (27.40%) (P<0.05) . The overall lifetime prevalence of affective disorders was 21.77%. To be specific, the lifetime prevalence of affective disorders was 17.14% in opioid use disorder group, 25.38% in methamphetamine use disorder group, and 24.66% in double use disorder group. The overall lifetime prevalence of alcohol use disorder was 42.18%. Specifically, opioid use disorder group had lower lifetime prevalence of alcohol use disorder than methamphetamine use disorder group (35.10% vs 45.69%) and than double use disorder group (35.10% vs 49.32%) (P<0.05) . The overall lifetime prevalence of sedative or hypnotic use disorder was 13.61%. The lifetime prevalence of sedative or hypnotic use disorder was 19.18%, 22.60% and 0 in opioid use disorder group, double use disorder group, and methamphetamine use disorder group, respectively. Conclusion The prevalence of the above-mentioned mental disorders in drug users in Yunnan Province was much higher than that in the general population. Moreover, these mental disorders may be even more prevalent in methamphetamine use disorder population than in opioid use disorder population. |
| abstract_unstemmed |
Background Mental disorders in drug users have received increasing attention. However, there are no any epidemiologic data available in regard to substance use disorders (SUD) and other mental disorders in drug users in Yunnan, one region that is hit hardest by epidemic of drug use in China. Objective To investigate the co-prevalence of SUD and a common mental disorder, axisⅠdisorders, among Yunnan's drug users. Methods A cross-sectional survey was conducted among a convenient sample of 598 male drug users who received detoxification treatment from the 5th Compulsory Detention and Forced Detoxification Center of Yunnan Province and Dali Compulsory Detention and Forced Detoxification Center between August and November, 2020. According to the diagnosis of SUD, the participants were divided into three groups: opioid use disorder group (n=245) , methamphetamine use disorder group (n=197) and double use disorder group (n=146) . The Chinese version of SCID-Ⅰ/P was used to assess the prevalence of common axisⅠmental disorders (psychosis disorder, affective disorder, alcohol use disorder, and sedative-hypnotic use disorder) . The lifetime prevalence of these disorders among the three groups was compared. Results Among the 598 cases, there were 588 cases diagnosed with SUD (opioid, methamphetamine, or both) . The lifetime prevalence of psychosis disorder, alcohol use disorder, sedative and hypnotic use disorder among the three groups was significantly different (P < 0.05) . The overall lifetime prevalence of schizophrenia, other primary and drug induced psychotic disorders was 15.82%. The lifetime prevalence of psychotic disorder in opioid use disorder group (5.31%) was lower than that of methamphetamine use disorder group (20.30%) or that of double use disorder group (27.40%) (P<0.05) . The overall lifetime prevalence of affective disorders was 21.77%. To be specific, the lifetime prevalence of affective disorders was 17.14% in opioid use disorder group, 25.38% in methamphetamine use disorder group, and 24.66% in double use disorder group. The overall lifetime prevalence of alcohol use disorder was 42.18%. Specifically, opioid use disorder group had lower lifetime prevalence of alcohol use disorder than methamphetamine use disorder group (35.10% vs 45.69%) and than double use disorder group (35.10% vs 49.32%) (P<0.05) . The overall lifetime prevalence of sedative or hypnotic use disorder was 13.61%. The lifetime prevalence of sedative or hypnotic use disorder was 19.18%, 22.60% and 0 in opioid use disorder group, double use disorder group, and methamphetamine use disorder group, respectively. Conclusion The prevalence of the above-mentioned mental disorders in drug users in Yunnan Province was much higher than that in the general population. Moreover, these mental disorders may be even more prevalent in methamphetamine use disorder population than in opioid use disorder population. |
| collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ |
| container_issue |
36 |
| title_short |
Co-prevalence of Substance Use Disorders and Common AxisⅠDisorders in Yunnan's Drug Users |
| url |
https://doi.org/10.12114/j.issn.1007-9572.2022.0426 https://doaj.org/article/a51c860eed184d38b267f2ff189b1b8f https://www.chinagp.net/fileup/1007-9572/PDF/zx20220426.pdf https://doaj.org/toc/1007-9572 |
| remote_bool |
true |
| ppnlink |
DOAJ090664779 |
| mediatype_str_mv |
c |
| isOA_txt |
true |
| hochschulschrift_bool |
false |
| doi_str |
10.12114/j.issn.1007-9572.2022.0426 |
| up_date |
2024-07-03T20:44:17.797Z |
| _version_ |
1803592094499995648 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000naa a22002652 4500</leader><controlfield tag="001">DOAJ091500354</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20240412094020.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">240412s2022 xx |||||o 00| ||chi c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.12114/j.issn.1007-9572.2022.0426</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ091500354</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJa51c860eed184d38b267f2ff189b1b8f</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">chi</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">ZHANG Guanbai, ZHENG Ling, YANG Liping, ZHOU Qin, WANG Fei, HE Liangze, CHENG Xuan, CHA Li, LI Xinyue</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Co-prevalence of Substance Use Disorders and Common AxisⅠDisorders in Yunnan's Drug Users</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2022</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Background Mental disorders in drug users have received increasing attention. However, there are no any epidemiologic data available in regard to substance use disorders (SUD) and other mental disorders in drug users in Yunnan, one region that is hit hardest by epidemic of drug use in China. Objective To investigate the co-prevalence of SUD and a common mental disorder, axisⅠdisorders, among Yunnan's drug users. Methods A cross-sectional survey was conducted among a convenient sample of 598 male drug users who received detoxification treatment from the 5th Compulsory Detention and Forced Detoxification Center of Yunnan Province and Dali Compulsory Detention and Forced Detoxification Center between August and November, 2020. According to the diagnosis of SUD, the participants were divided into three groups: opioid use disorder group (n=245) , methamphetamine use disorder group (n=197) and double use disorder group (n=146) . The Chinese version of SCID-Ⅰ/P was used to assess the prevalence of common axisⅠmental disorders (psychosis disorder, affective disorder, alcohol use disorder, and sedative-hypnotic use disorder) . The lifetime prevalence of these disorders among the three groups was compared. Results Among the 598 cases, there were 588 cases diagnosed with SUD (opioid, methamphetamine, or both) . The lifetime prevalence of psychosis disorder, alcohol use disorder, sedative and hypnotic use disorder among the three groups was significantly different (P &lt; 0.05) . The overall lifetime prevalence of schizophrenia, other primary and drug induced psychotic disorders was 15.82%. The lifetime prevalence of psychotic disorder in opioid use disorder group (5.31%) was lower than that of methamphetamine use disorder group (20.30%) or that of double use disorder group (27.40%) (P&lt;0.05) . The overall lifetime prevalence of affective disorders was 21.77%. To be specific, the lifetime prevalence of affective disorders was 17.14% in opioid use disorder group, 25.38% in methamphetamine use disorder group, and 24.66% in double use disorder group. The overall lifetime prevalence of alcohol use disorder was 42.18%. Specifically, opioid use disorder group had lower lifetime prevalence of alcohol use disorder than methamphetamine use disorder group (35.10% vs 45.69%) and than double use disorder group (35.10% vs 49.32%) (P&lt;0.05) . The overall lifetime prevalence of sedative or hypnotic use disorder was 13.61%. The lifetime prevalence of sedative or hypnotic use disorder was 19.18%, 22.60% and 0 in opioid use disorder group, double use disorder group, and methamphetamine use disorder group, respectively. Conclusion The prevalence of the above-mentioned mental disorders in drug users in Yunnan Province was much higher than that in the general population. Moreover, these mental disorders may be even more prevalent in methamphetamine use disorder population than in opioid use disorder population.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">substance-related disorders|opioid-related disorders|methamphetamine|schizophrenia|psychotic disorders|drug users|yunnan|cross-sectional studies</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Medicine</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">R</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Zhongguo quanke yixue</subfield><subfield code="d">Chinese General Practice Publishing House Co., Ltd, 2024</subfield><subfield code="g">25(2022), 36, Seite 4554-4560</subfield><subfield code="w">(DE-627)DOAJ090664779</subfield><subfield code="x">10079572</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:25</subfield><subfield code="g">year:2022</subfield><subfield code="g">number:36</subfield><subfield code="g">pages:4554-4560</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.12114/j.issn.1007-9572.2022.0426</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/a51c860eed184d38b267f2ff189b1b8f</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://www.chinagp.net/fileup/1007-9572/PDF/zx20220426.pdf</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1007-9572</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">25</subfield><subfield code="j">2022</subfield><subfield code="e">36</subfield><subfield code="h">4554-4560</subfield></datafield></record></collection>
|
| score |
7.3998165 |